India
· Delayed Price · Currency is INR Sequent Scientific Company Description
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.
The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology.
It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products.
The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009.
The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
| Country | India |
| Founded | 1985 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,195 |
| CEO | Rajaram Narayanan |
Contact Details
Address: Dosti Pinnacle Mumbai, 400604 India | |
| Phone | 91 22 4111 4777 |
| Website | sequent.in |
Stock Details
| Ticker Symbol | 512529 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rajaram Narayanan | Chief Executive Officer |
| Saurav Bhala | Chief Financial Officer |
| Abhishek Singhal | Head of Investor Relations |